The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 19, 2022
Filed:
Aug. 30, 2017
Applicant:
Aerie Pharmaceuticals, Inc., Bedminster, NJ (US);
Inventors:
Cheng-Wen Lin, Raleigh, NC (US);
Casey Kopczynski, Chapel Hill, NC (US);
Mitchell A. deLong, Chapel Hill, NC (US);
Jill M. Sturdivant, Chapel Hill, NC (US);
Ramesh Krishnamoorthy, Cary, NC (US);
Assignee:
Aerie Pharmaceuticals, Inc., Bedminster, NJ (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/472 (2006.01); A61K 9/08 (2006.01); A61K 45/06 (2006.01); A61K 47/02 (2006.01); A61K 47/26 (2006.01); A61K 9/00 (2006.01); A61K 31/5575 (2006.01); A61K 47/18 (2017.01);
U.S. Cl.
CPC ...
A61K 31/472 (2013.01); A61K 9/0048 (2013.01); A61K 9/08 (2013.01); A61K 31/5575 (2013.01); A61K 45/06 (2013.01); A61K 47/02 (2013.01); A61K 47/186 (2013.01); A61K 47/26 (2013.01);
Abstract
The present disclosure provides an ophthalmic composition comprising 4-(3-amino-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate or its pharmaceutically acceptable salts; about 0.01% weight/volume to about 1.0% weight/volume of a buffer; and about 0.01% weight/volume to about 10% weight/volume of a tonicity agent.